BioSpace News Archive

Genetown

New CDC Guidelines Endorse Opt-Out Screening for Two of the Most Common Sexually Transmitted Infections (STIs), Recommend Nucleic Acid Testing for Mycoplasma Genitalium

Hologic, Inc. (Nasdaq: HOLX) commends the decision by the United States Centers for Disease Control and Prevention (CDC) to endorse an updated approach to screening for Chlamydia trachomatis and Neisseria gonorrhoea, two of the most common sexually transmitted infections (STIs) in the country.

July 26, 2021
·
8 min read
Biotech Bay

Twist Bioscience Incorporates MOLCURE AI Technology to Augment Therapeutic Antibody Discovery

Twist Bioscience Corporation today announced they generated potent, binding antibodies to an undisclosed oncology target for Twist’s internal pipeline of antibody candidates.

July 26, 2021
·
4 min read
Business

4D pharma Announces Passing of Chief Financial Officer John Beck

4D pharma plc announces with great sadness that John Beck, Chief Financial Officer of 4D pharma, has passed away.

July 26, 2021
·
2 min read
BiomX Inc. Announces $15 Million Registered Direct Offering

The securities are being sold at an offering price of $4.00 per share of the Company’s common stock and an accompanying warrant to purchase 0.75 of a share of the Company’s common stock at an exercise price of $5.00 per share.

July 26, 2021
·
4 min read
Drug Development

INmune Bio, Inc. Announces Design of Upcoming Phase 2 Alzheimer’s Disease Clinical Trial and New Phase 1b AD Biomarker Data

INmune Bio, Inc. today announced the design of its upcoming Phase 2 clinical trial of XProTM in patients diagnosed with mild Alzheimer’s disease (AD).

July 26, 2021
·
7 min read
Sharecare to participate in 41st Annual Canaccord Genuity Growth Conference

Sharecare will participate in the 41st Annual Canaccord Genuity Growth Conference, including a presentation on Thursday, August 12, 2021

July 26, 2021
·
1 min read
Drug Development

SciSparc Announces Updates Regarding its Phase IIb Study in Tourette Syndrome

SciSparc Ltd. (OTCQB: SPRCY), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, today announced a number of updates regarding its Phase IIb clinical study in Tourette Syndrome using the proprietary cannabinoid-based treatment- SCI-110.

July 26, 2021
·
3 min read
Policy

Quidel Announces Agreement With Beckman Coulter That Terminates Ongoing Litigation and Transitions BNP Business to Beckman Coulter

Settlement Agreement ends litigation that began in November 2017, following Quidel’s acquisition of the BNP Business from Alere, Inc. (“Alere”). Quidel to receive cash payments between $70 million to $75 million per year through 2029

July 26, 2021
·
8 min read
Pharm Country

Champions Oncology Announces an Expanded Corporate Strategy to Include Drug Discovery and Development

Champions Oncology, Inc., a leading global oncology technology solutions provider that is transforming drug discovery through innovative pharmacology, biomarker, and data platforms, announced an expansion of its corporate strategy as they unveil their entry into the drug discovery and development space.

July 26, 2021
·
5 min read
Pharm Country

LifeMD to Release Second Quarter 2021 Financial Results on Thursday, August 12, 2021Hosted conference call to begin at 4:30 p.m. ET

LifeMD, Inc. (“the Company”) (NASDAQ: LFMD) is a rapidly growing direct-to-patient telehealth company that offers cash pay virtual medical treatment, prescription medications and over the counter products to patients across all 50 states.

July 26, 2021
·
2 min read